Results 171 to 180 of about 115,544 (313)
reservedProblema: il delirium postoperatorio (POD) è una complicanza neuropsichiatrica frequente nei pazienti sottoposti a intervento chirurgico, con un impatto significativo sulla prognosi clinica e sui costi sanitari.
MEMEO, FRANCESCA
core
ABSTRACT The 2024 International Conference on Functional Neurological Disorders brought together clinicians, researchers, advocates, and service‐user representatives to discuss recent developments in functional neurological disorder and related functional disorders.
Yadira Velazquez‐Rodriquez +2 more
wiley +1 more source
Effect of Remimazolam on Postoperative Delirium in Surgical ICU Patients: A Single-Center Prospective Cohort Study. [PDF]
Hong J, Zhao C, Lin L.
europepmc +1 more source
openPROBLEMA: Il delirium è una sindrome complessa caratterizzata da disturbi della coscienza, dell’attenzione, della memoria, della percezione, del pensiero, molto frequente nei contesti di Cure Palliative e nei pazienti oncologici terminali ...
TOLLARDO, GIORGIA
core
Attentional fluctuations in hospitalized older adults: an investigation of Vigilance in relation to Delirium [PDF]
openINTRODUZIONE: Il delirium è un disturbo neurocognitivo ad esordio acuto, caratterizzato da alterazioni di attenzione, memoria, funzioni esecutive, comportamento psicomotorio, emozioni e ritmo sonno-veglia. Peculiare è l’andamento clinico fluttuante,
CASTAGNA, GENNY
core
Abstract Background Subcutaneous foslevodopa‐foscarbidopa (SCFF) is a novel, non‐surgical dopaminergic infusion therapy for better controlling motor fluctuations in advanced Parkinson's disease (PD). However, there are scarce real‐world data on efficacy, adverse events and comparisons with other infusion strategies. Objectives Here, we aimed to provide
Johannes Hartig +6 more
wiley +1 more source
Components and effects of psychosocial support interventions for relatives of patients with delirium in hospitals, systematic review. [PDF]
Grebe M, Dichter MN, Dano R, Köpke S.
europepmc +1 more source
Abstract Background SUNRISE‐PD was a dose‐escalating, phase 1/2 study investigating a second‐generation lentiviral vector gene therapy delivering the genes for dopamine synthesis (OXB‐102) to treat Parkinson's disease (PD). The trial was prematurely terminated due to insolvency of the sponsor.
Simon Rowe +19 more
wiley +1 more source
The ICU environment paradigm as a catalyst for better delirium models. [PDF]
Carr ZJ.
europepmc +1 more source
ABSTRACT Aims Urinary incontinence (UI) is a prevalent condition among adults and imposes a substantial societal burden, yet its association with all‐cause mortality remains uncertain. This study systematically reviewed and quantified the association between UI and mortality risk.
Yanyan Zhou +6 more
wiley +1 more source

